ArticleThe Lancet regional health. Europe2026

Effectiveness and Safety of Semaglutide in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018-2024).

Puriya Daniel Würtz Yazdanfard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.